Drug Program Needs Attention

coapharm2017-10-19T20:20:29+00:00October 19, 2017|

Cutting-Edge Immunotherapy Treatment Approved for Another Deadly Cancer

coapharm2017-10-19T20:19:09+00:00October 19, 2017|

Pharmaceutical Middle Men Reforms Would Save Patients and Taxpayers Billions

coapharm2017-10-19T20:17:26+00:00October 19, 2017|

Drug Supply Players Point a Finger Everywhere But Themselves

coapharm2017-10-18T20:29:21+00:00October 18, 2017|

The Need for Transparency with DIR Fees

coapharm2017-10-18T20:27:45+00:00October 18, 2017|

What Are the Key Strategies Necessary to Marketing a Community Pharmacy?

coapharm2017-10-17T16:24:02+00:00October 17, 2017|

How Can Pharmacists Best Address the Issue of Medication Adherence with Patients?

coapharm2017-10-17T16:22:54+00:00October 17, 2017|

New Analysis: 340B Program Shifting Delivery of Physician-Administered Medicines to More Expensive Hospital Settings

coapharm2017-10-17T14:55:46+00:00October 17, 2017|

Outpatient Drug Therapies Shift from Physician to Hospital Setting

coapharm2017-10-17T14:52:07+00:00October 17, 2017|

Pharmacy’s Changing Role as Cancer Care Transitions From Infused to Oral Therapies

coapharm2017-10-16T17:40:35+00:00October 16, 2017|